Capital Performance Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$201K	Buy	+1,603	New	+$201K	0.04%	252
2025 Q1	–	Sell	-1,730	Closed	-$236K	–	275
2024 Q4	$236K	Buy	1,730 +1,586	+1,101%	+$216K	0.08%	129
2024 Q3	$16.6K	Buy	+144	New	+$16.6K	0.01%	663